Content area
Abstract
A 45-YEAR-OLD WOMAN PRESENTED WITH TYPE V PHENOTYPE, MIXED hyperlipemia and secondary type 2 diabetes mellitus. Her diseases were managed with insulin and oral hypoglycemic agents with combined n-3 fatty acids-orlistat-fibrate-statin lipid-lowering therapy.